FTSE All-Share
5.663,90
PKT
+35,12
PKT
+0,62
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.08.12 | National Grid buy | Nomura | |
| 24.08.12 | Anglo American neutral | Sarasin Research | |
| 24.08.12 | Anglo American buy | Deutsche Bank AG | |
| 24.08.12 | Tullow Oil overweight | Morgan Stanley | |
| 23.08.12 | GSK buy | Citigroup Corp. | |
| 23.08.12 | Lloyds Banking Group buy | Deutsche Bank AG | |
| 23.08.12 | BT Group neutral | Goldman Sachs Group Inc. | |
| 23.08.12 | Glencore neutral | Exane-BNP Paribas SA | |
| 23.08.12 | Diageo hold | ING | |
| 23.08.12 | Antofagasta underperform | RBC Capital Markets | |
| 23.08.12 | Tullow Oil hold | Société Générale Group S.A. (SG) | |
| 23.08.12 | Vodafone Group outperform | Sanford C. Bernstein and Co., Inc. | |
| 22.08.12 | Shell (ex Royal Dutch Shell) buy | ING | |
| 22.08.12 | Glencore buy | Société Générale Group S.A. (SG) | |
| 22.08.12 | Glencore sector perform | RBC Capital Markets | |
| 22.08.12 | Antofagasta overweight | J.P. Morgan Cazenove | |
| 22.08.12 | Hays buy | UBS AG | |
| 22.08.12 | Wm Morrison Supermarkets sell | Goldman Sachs Group Inc. | |
| 22.08.12 | Glencore neutral | Sarasin Research | |
| 22.08.12 | Aberdeen Group hold | Deutsche Bank AG | |
| 22.08.12 | BAE Systems buy | UBS AG | |
| 22.08.12 | Persimmon buy | UBS AG | |
| 22.08.12 | Kingfisher hold | Deutsche Bank AG | |
| 22.08.12 | HSBC buy | Citigroup Corp. | |
| 21.08.12 | Diageo buy | Deutsche Bank AG | |
| 21.08.12 | Rio Tinto buy | Citigroup Corp. | |
| 21.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 21.08.12 | Diageo neutral | Exane-BNP Paribas SA | |
| 21.08.12 | Weir Group buy | Deutsche Bank AG | |
| 21.08.12 | Glencore neutral | UBS AG | |
| 20.08.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 20.08.12 | BP overweight | J.P. Morgan Cazenove | |
| 17.08.12 | AstraZeneca underperform | Credit Suisse Group | |
| 17.08.12 | BP outperform | RBC Capital Markets | |
| 16.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
| 16.08.12 | Diageo buy | UBS AG | |
| 16.08.12 | GSK neutral | Goldman Sachs Group Inc. | |
| 16.08.12 | Vodafone Group buy | Goldman Sachs Group Inc. | |
| 16.08.12 | Vodafone Group neutral | Banc of America Securities-Merrill Lynch | |
| 16.08.12 | Standard Chartered buy | Nomura |